Labroots

Molecular GI testing: Advancing diagnostic stewardship and optimizing patient management

Gastrointestinal (GI) infections present a formidable challenge to healthcare systems. As we navigate this landscape, we recognize that there are numerous benefits when moving from conventional to ...
Labroots

Advancing Gastrointestinal (GI) infection diagnosis and management:

Join us for a compelling webinar that delves into gastrointestinal pathogen diagnostics and the crucial role of targeted testing options in routine patient care. A Microbiology and Virology Medical ...
Hébergé sur MSN

The Dietitians Guide to a GI-MAP Test

Research continues to link the gut to nearly every facet of our health. Could the GI-MAP be key to understanding our patients’ microbial health? The GI tract is the residence of trillions of ...
Hébergé sur MSN

FDA clears Cepheid’s Xpert GI panel for pathogen detection

Cepheid has received clearance from the US Food and Drug Administration (FDA) for its Xpert GI Panel, a multiplex polymerase chain reaction (PCR) gastrointestinal (GI) pathogen testing solution. The ...
Healio

FDA-cleared GI test detects ‘most likely causes’ of diarrheal syndromes

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The test aids in detecting eight bacteria, two parasites ...
Business Wire

QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System

GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the use of ...